Double-blind, parallel group study to evaluate efficacy and safety of linagliptin 5 mg compared to placebo, administered as oral fixed dose combination with empagliflozin 10 or 25mg on metformin backg

  • Gerstman, Murray (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date24/01/13 → 28/02/14